
Pharma Weekly Updates in a Quick, 2-Minute Read.
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 157 | Founded | 3 years ago | Last Issue | 5 days ago |
| Active | |||||

This edition is sponsored by AzurBio - supporting biotech and pharma companies looking to enter, understand, and grow in the European market.
🤝 Servier will acquire Edgewise Therapeutics’ muscular dystrophy business for up to $...
🤝 Pfizer signed a $10.5B oncology licensing deal with Innovent Biologics covering 12 early programs, including ADCs and multispecific antibodies.
💰 GHO Capital and CBC Group will merge into a $21B healthcare investment giant, creating th...
🟢 FDA approved AstraZeneca’s Baxfendy for resistant hypertension, the 1st novel blood-pressure mechanism in 2 decades with multibillion-dollar annual sales potential.
🚨 World Health Organization raised its 2nd-highest international alert...
🤝 Bristol Myers Squibb signed a $15.2B broad licensing deal with Jiangsu Hengrui covering 13 early-stage oncology, hematology, and immunology programs.
🏛️ FDA Commissioner Marty Makary has departed, and acting drug center head Tracy Beth...
🤝 Angelini Pharma will acquire Catalyst Pharmaceuticals, Inc. for about $4.1B, gaining rare neurology drugs and a U.S. commercial platform.
🤝 UCB will acquire Candid Therapeutics for up to $2.2B, adding a promising autoimmune disease tre...
Subscribers, engagement, traffic and sponsorship for \ud83d\udd2c Latest Pharma Industry Updates.
| Subscribers | Engagement | 69 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #238 |
The writers behind this newsletter.
Pharma Senior Market Analyst providing weekly updates about the Life science industry.
You can find recent issues that have been published by this newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to this newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch this newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact this newsletter using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like this newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.